2023 annual financial data
Context Therapeutics 2023 Net margin
Context Therapeutics 2023 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -25,072,616 USD and net income was -23,964,211 USD.
Operating cash flow was -21,047,618 USD.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -25,072,616 USD
- Net income
- -23,964,211 USD
- Operating cash flow
- -21,047,618 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Context Therapeutics financial years